Lobo Valentine A
Department of Nephrology, King Edward Memorial Hospital, Pune, Maharashtra, India.
Indian J Crit Care Med. 2020 Aug;24(8):624-625. doi: 10.5005/jp-journals-10071-23540.
Recent trials have failed to show a survival benefit from the early initiation of dialytic therapies in acute kidney injury (AKI), but the problem has not been studied in pregnancy-related AKI. While the KDIGO criteria have not been validated in pregnancy-related acute kidney injury (PRAKI), additionally both fetal and maternal outcomes require to be studied. The short observational study by Banerjee et al. contains some interesting observations.
Lobo VA. Renal Replacement Therapy in Pregnancy-related Acute Kidney Injury: Getting the Timing Right. Indian J Crit Care Med 2020;24(8):624-625.
近期试验未能证明急性肾损伤（AKI）早期开始透析治疗能带来生存获益，但妊娠相关急性肾损伤尚未对此问题进行研究。虽然KDIGO标准在妊娠相关急性肾损伤（PRAKI）中尚未得到验证，但胎儿和母亲的结局都需要进行研究。Banerjee等人的短期观察性研究包含了一些有趣的观察结果。
Lobo VA。妊娠相关急性肾损伤的肾脏替代治疗：把握正确时机。《印度重症监护医学杂志》2020年；24（8）：624 - 625。
